We are live on ! Find out more
BNR

Burning Rock Biotech

42 hedge funds and large institutions have $49.5M invested in Burning Rock Biotech in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% less ownership

Funds ownership: 2.65%2.5% (-0.15%)

6% less capital invested

Capital invested by funds: $52.5M → $49.5M (-$2.96M)

19% less funds holding

Funds holding: 5242 (-10)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

65% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 20

Holders
42
Holders Change
-10
Holders Change %
-19.23%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
7
Reduced
20
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
-$63K -2,601 Closed
XT
52
XTX Topco
Cayman Islands
-$60K -2,520 Closed
Northern Trust
53
Northern Trust
Illinois
-$38K -1,600 Closed
VF
54
Virtu Financial
New York
-$31K -1,314 Closed
CS
55
Credit Suisse
Switzerland
-$16K -682 Closed
Legal & General Group
56
Legal & General Group
United Kingdom
-$14K -579 Closed
US Bancorp
57
US Bancorp
Minnesota
-$2K -79 Closed
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
+$46 +2 New

BNR Hedge Fund Activity: Q4 2022 in Review

42 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2022, worth a combined $49.5M — down 5.6% from $52.5M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BNR and 8 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 7 added.

The largest buyer was Fidelity International, opening a new position worth an estimated $6.41M. The largest seller was BlackRock, cutting an estimated $3.44M.

  • 42 institutional investors held Burning Rock Biotech (BNR) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $49.5M of Burning Rock Biotech stock for Q4 2022, down 5.6% quarter-over-quarter.
  • 8 funds opened new Burning Rock Biotech positions in Q4 2022 and 18 closed out, a net change of -10 holders.
  • The largest Burning Rock Biotech buyer in Q4 2022 was Fidelity International, an estimated $6.41M added.
  • The largest Burning Rock Biotech seller in Q4 2022 was BlackRock, an estimated $3.44M sold.

Based on aggregated 13F filings for Q4 2022.